Literature DB >> 24671055

Pharmacological characterization of standard analgesics on oxaliplatin-induced acute cold hypersensitivity in mice.

Meng Zhao1, Saki Nakamura, Takahito Miyake, Kanako So, Hisashi Shirakawa, Shogo Tokuyama, Minoru Narita, Takayuki Nakagawa, Shuji Kaneko.   

Abstract

Oxaliplatin, a platinum-based chemotherapeutic agent, causes an acute peripheral neuropathy triggered by cold in almost all patients during or within hours after its infusion. We recently reported that a single administration of oxaliplatin induced cold hypersensitivity 2 h after the administration in mice. In this study, we examined whether standard analgesics relieve the oxaliplatin-induced acute cold hypersensitivity. Gabapentin, tramadol, mexiletine, and calcium gluconate significantly inhibited and morphine and milnacipran decreased the acute cold hypersensitivity, while diclofenac and amitriptyline had no effects. These results suggest that gabapentin, tramadol, mexiletine, and calcium gluconate are effective against oxaliplatin-induced acute peripheral neuropathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24671055     DOI: 10.1254/jphs.13249sc

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  8 in total

Review 1.  Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics.

Authors:  Holly L Hopkins; Natalie A Duggett; Sarah J L Flatters
Journal:  Curr Opin Support Palliat Care       Date:  2016-06       Impact factor: 2.302

2.  Low-level laser therapy alleviates mechanical and cold allodynia induced by oxaliplatin administration in rats.

Authors:  Y-L Hsieh; Y-C Fan; C-C Yang
Journal:  Support Care Cancer       Date:  2015-05-26       Impact factor: 3.603

3.  Psycho-physiological response to pain among individuals with comorbid pain and opioid use disorder: Implications for patients with prolonged abstinence.

Authors:  Amy Wachholtz; Gerardo Gonzalez; Douglas Ziedonis
Journal:  Am J Drug Alcohol Abuse       Date:  2019-06-27       Impact factor: 3.829

4.  Pharmacological comparison of a nonhuman primate and a rat model of oxaliplatin-induced neuropathic cold hypersensitivity.

Authors:  Yuka Shidahara; Shinya Ogawa; Mari Nakamura; Shingo Nemoto; Yuji Awaga; Miyuki Takashima; Aldric Hama; Akihisa Matsuda; Hiroyuki Takamatsu
Journal:  Pharmacol Res Perspect       Date:  2016-02-08

Review 5.  Gaps in Understanding Mechanism and Lack of Treatments: Potential Use of a Nonhuman Primate Model of Oxaliplatin-Induced Neuropathic Pain.

Authors:  Aldric Hama; Takahiro Natsume; Shin'ya Ogawa; Noriyuki Higo; Ikuo Hayashi; Hiroyuki Takamatsu
Journal:  Pain Res Manag       Date:  2018-05-02       Impact factor: 3.037

6.  Semi-Mechanism-Based Pharmacokinetic-Toxicodynamic Model of Oxaliplatin-Induced Acute and Chronic Neuropathy.

Authors:  Shinji Kobuchi; Risa Shimizu; And Yukako Ito
Journal:  Pharmaceutics       Date:  2020-02-03       Impact factor: 6.321

7.  Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice.

Authors:  Hichem Bouchenaki; Aurore Danigo; Amandine Bernard; Flavien Bessaguet; Laurence Richard; Franck Sturtz; David Balayssac; Laurent Magy; Claire Demiot
Journal:  Front Pharmacol       Date:  2021-07-19       Impact factor: 5.810

8.  Cold sensitivity of TRPA1 is unveiled by the prolyl hydroxylation blockade-induced sensitization to ROS.

Authors:  Takahito Miyake; Saki Nakamura; Meng Zhao; Kanako So; Keisuke Inoue; Tomohiro Numata; Nobuaki Takahashi; Hisashi Shirakawa; Yasuo Mori; Takayuki Nakagawa; Shuji Kaneko
Journal:  Nat Commun       Date:  2016-09-15       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.